| Epidermal growth factor receptor (EGFR)-targeted photoimmunotherapy (PIT) for the treatment of EGFR-expressing bladder cancer R Railkar, LS Krane, QQ Li, T Sanford, MR Siddiqui, D Haines, ... Molecular cancer therapeutics 16 (10), 2201-2214, 2017 | 88 | 2017 |
| Photodynamic therapy in the treatment of bladder cancer: past challenges and current innovations R Railkar, PK Agarwal European urology focus 4 (4), 509-511, 2018 | 83 | 2018 |
| Targeting epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2) expressing bladder cancer using combination photoimmunotherapy (PIT) MR Siddiqui, R Railkar, T Sanford, DR Crooks, MA Eckhaus, D Haines, ... Scientific reports 9 (1), 2084, 2019 | 68 | 2019 |
| Protein kinase D inhibitor CRT0066101 suppresses bladder cancer growth in vitro and xenografts via blockade of the cell cycle at G2/M QQ Li, I Hsu, T Sanford, R Railkar, N Balaji, C Sourbier, C Vocke, ... Cellular and molecular life sciences 75, 939-963, 2018 | 38 | 2018 |
| Novel anti IGFBP2 single chain variable fragment inhibits glioma cell migration and invasion SS Patil, R Railkar, M Swain, HS Atreya, RR Dighe, P Kondaiah Journal of Neuro-Oncology 123, 225-235, 2015 | 36 | 2015 |
| Integrative analysis of the epigenetic basis of muscle-invasive urothelial carcinoma T Sanford, MV Meng, R Railkar, PK Agarwal, SP Porten Clinical epigenetics 10, 1-11, 2018 | 23 | 2018 |
| Surface modification of PDMS using atmospheric glow discharge polymerization of tetrafluoroethane for immobilization of biomolecules V Anand, S Ghosh, M Ghosh, GM Rao, R Railkar, RR Dighe Applied surface science 257 (20), 8378-8384, 2011 | 16 | 2011 |
| Insights into differential modulation of receptor function by hinge region using novel agonistic lutropin receptor and inverse agonistic thyrotropin receptor antibodies R Majumdar, R Railkar, RR Dighe FEBS letters 586 (6), 810-817, 2012 | 13 | 2012 |
| Docking and free energy simulations to predict conformational domains involved in hCG–LH receptor interactions using recombinant antibodies R Majumdar, R Railkar, RR Dighe Proteins: Structure, Function, and Bioinformatics 79 (11), 3108-3122, 2011 | 12 | 2011 |
| Proteasome inhibition disrupts the metabolism of fumarate hydratase-deficient tumors by downregulating p62 and c-Myc C Sourbier, CJ Ricketts, PJ Liao, S Matsumoto, D Wei, M Lang, R Railkar, ... Scientific Reports 9 (1), 18409, 2019 | 9 | 2019 |
| The antibodies against the computationally designed mimic of the glycoprotein hormone receptor transmembrane domain provide insights into receptor activation and suppress the … R Majumdar, R Railkar, RR Dighe Journal of Biological Chemistry 287 (41), 34514-34532, 2012 | 7 | 2012 |
| MP16-14 clinical outcomes of a randomized, prospective, phase ii study to determine the efficacy of bacillus calmette-guerin (BCG) given in combination with panvac versus BCG … R Saoud, S Telfer, M Maruf, E Singer, R Weiss, T Jang, S Elsamra, ... Journal of Urology 206 (Supplement 3), e302, 2021 | 6 | 2021 |
| Photocytotoxic and anaerobic DNA cleavage activity of binuclear 3, 3′-dithiodipropionic acid cobalt (II) complexes having phenanthroline bases D Lahiri, T Bhowmick, B Banik, R Railkar, S Ramakumar, RR Dighe, ... Polyhedron 29 (12), 2417-2425, 2010 | 6 | 2010 |
| Targeting epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 expressing bladder cancer using combination photoimmunotherapy (PIT). MR Siddiqui, RS Railkar, T Sanford, PL Choyke, H Kobayashi, ... Journal of Clinical Oncology 35 (15_suppl), e16026-e16026, 2017 | 3 | 2017 |
| Flavoperidol as a novel therapeutic agent for bladder cancer. R Railkar, T Sanford, S Krane, QQ Li, PK Agarwal Journal of Clinical Oncology 35 (6_suppl), 357-357, 2017 | 1 | 2017 |
| Targeting urothelial neoplasia using an investigational virus-like drug conjugate. R Kines, RS Railkar, PK Agarwal, JT Schiller Journal of Clinical Oncology 40 (6_suppl), 514-514, 2022 | | 2022 |
| Photoimmunotherapy (PIT) for treatment of bladder cancer. R Railkar, MR Siddiqui, T Sanford, H Kobayashi, PL Choyke, PK Agarwal CLINICAL CANCER RESEARCH 26 (15), 35-35, 2020 | | 2020 |
| Abstract A09: Photoimmunotherapy (PIT) for treatment of bladder cancer R Railkar, MR Siddiqui, T Sanford, H Kobayashi, PL Choyke, PK Agarwal Clinical Cancer Research 26 (15_Supplement), A09-A09, 2020 | | 2020 |
| MP57-05 NOVEL DEEP LEARNING COMPUTER VISION APPROACH FOR DRUG SENSITIVITY PREDICTION T Sanford*, R Railkar, S Harmon, S Xu, B Wood, P Choyke, B Turkbey, ... The Journal of Urology 201 (Supplement 4), e814-e814, 2019 | | 2019 |
| Mechanisms underlying the inhibitory effect of CRT0066101 on bladder cancer growth in vitro and in vivo Q Li, I Hsu, R Railkar, T Sanford, PK Agarwal Cancer Research 78 (13_Supplement), 4301-4301, 2018 | | 2018 |
Louis S KraneTulane University School of MedicineVerified email at tulane.edu
